Tag Archives: pharmaceutical companies

The Huffington Post— Creating Disease: Big Pharma and Disease Mongering

You may think there is enough disease in the world already, and that no one would want to add to the diseases that we humans must deal with. But there is a powerful industry in our society that is working overtime to invent illnesses and to convince us we are suffering from them. This effort is known as “disease mongering,” a term introduced by health-science writer Lynn Payer in her 1992 book Disease-Mongers: How Doctors, Drug Companies, and Insurers Are Making You Feel Sick.

Hooked on SSRIs:Antidepressant Use Doubles in the U.S.—Drugs not improving mental health but suicide rates are climbing

Antidepressant use more than doubled in the United States between 1996 and 2005, according to a study conducted by researchers from the University of Columbia and University of Pennsylvania and published in the Archives of General Psychiatry.

Psychiatry & the United States of Affliction: Are You Normal or Finally Diagnosed?

Spend just a few minutes watching prime time television with its endless pageant of commercials for antidepressants and anti-anxiety meds and you start to wonder if USA really means the United States of Affliction. Such “direct to consumer” drug advertising ties into one of the most far-reaching criticisms in revising the Diagnostic and Statistical Manual of Mental Disorders…

“ADHD is a total 100% fraud. The millions of schoolchildren around the world being drugged have no disease” – Neurologist

The term “ADHD” is simply a label used to categorise a list of psychosocial traits that Psychiatry considers to be improper or abnormal in society. Psychiatry defines these traits as a “mental illness”, and promotes it as a “disease” that requires “treatment”.

Natural News: Children’s temper tantrums to be reclassified as mental disorders

Proposed changes to the U.S. Diagnostic and Statistical Manual (DSM) could include reclassifying childhood temper tantrums, teenage angst, and binge eating as psychiatric disorders. If accepted, the proposals could equal billions of dollars in new revenue for pharmaceutical companies.